Company News in the Life Science Industry

»

Reset 

Sensorion Presents New SENS-401 Data at ARO 2018 MidWinter Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Sensorion S.A

Novartis forms alliance to develop medicines for treating infectious diarrheal disease

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Novan, Inc.

DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018

Enzymatica AB: Strong growth and international breakthrough in 2017

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Enzymatica AB

Herantis Pharma opening recruitment in Parkinson's disease study in Helsinki and Lund based on favorable first CDNF safety assessment

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018

GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant

YONGIN, South Korea, Feb. 14, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical Holdings Limited ("Lee's Pharm") (SEHK: 0950)... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody

DÜSSELDORF, Germany and PARIS, February 14, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

Scientists Find a Pathway That Leads to Resistance of Aggressive Brain Tumor Treatment

LEBANON, N.H., Feb. 14, 2018 /PRNewswire/ -- Glioblastoma multiforme is one of the most common and deadly brain tumors. Despite the initial responsiveness to state-of-the-art therapies, tumors virtually always become resistant and eventually recur. Researchers at Dartmouth's Norris Cotton Cancer... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Lumenis Features Acoustics & Heat Experience and Introduces PicoFractional™ Technology at the American Academy of Dermatology Annual Meeting (AAD)

SAN DIEGO, Feb. 14, 2018 /PRNewswire/ -- Lumenis Ltd., the world's largest energy-based medical device company for aesthetic, surgical, and ophthalmic applications, is thrilled to unveil Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

United Therapeutics Corporation To Report Fourth Quarter And Annual 2017 Financial Results Before The Market Opens On Wednesday, February 21, 2018

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2017 financial results before the market opens on Wednesday, February 21, 2018.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  United Therapeutics Corporation

DaVita Kidney Care Encourages Americans to Become Organ Donors

DENVER, Feb. 14, 2018 /PRNewswire/ -- DaVita Kidney Care (NYSE: DVA), a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, supports National Donor Day and its patients with kidney... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  DaVita | DaVita Clinical Research

After multiple failed procedures at other medical institutions, Colorado man successfully treated for Atrial Fibrillation at Texas Cardiac Arrhythmia Institute at St. David's Medical Center

AUSTIN, Texas, Feb. 14, 2018 /PRNewswire/ -- Five years ago, Ryan Wiseman was in the prime of his life.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

National Research Corporation Announces Fourth Quarter and Year-End 2017 Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018

Cannabis Wheaton Income Corp. Announces Prior Engagement of Investor Relations Firms

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018

Astellas Acquires Universal Cells, Inc.

TOKYO, Feb. 13, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Universal Cells, Inc. (CEO: Claudia Mitchell, "Universal Cells") today announced that Astellas has acquired Universal Cells. Astellas will gain Universal Cells' proprietary... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  Astellas Pharma Inc.

Brain Imaging Helps Redefine Intelligence

NEW YORK, Feb. 13, 2018 /PRNewswire-USNewswire/ -- High-tech scans of the resting human brain can provide a new way to define and interpret the brain's actual mental capacity, new research suggests.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  NYU Langone Health | NYU Langone Medical Center- Cytometry & Cell Sorting Laboratory

Invitation to Novozymes' annual shareholders' meeting 2018

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018
Related companies:  Novozymes A/S

Avivagen to Seek Approval from TSX Venture Exchange for Extension of Warrants

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018
Related companies:  Avivagen Inc.

Initiation of stock buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018
Related companies:  Novozymes A/S

Amunix CEO to deliver keynote address on ProTIA, Amunix’s novel immuno-oncology technology, at the Biologics & Biosimilars Congress Europe (March 2018)

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2018
Related companies:  Amunix Operating Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies